The Kieger Healthcare team attended the 38th annual J.P. Morgan Healthcare Conference in San Francisco from January 13th to January 16th 2020.
Our overall conclusion from the conference is that the industry remains in good shape. Company presentations and management conversations across all subsectors were encouraging with innovation being key. While politics are impacting stock prices and we expect a continuation of the high volatility environment, impactful US policy changes seem unlikely ahead of the Presidential elections.
Rarely are health inequalities more apparent than when walking around San Francisco during the J.P. Morgan Healthcare Conference. In our chart of the month, Raphael Oesch (Portfolio Manager), takes a look at the statistics and discusses some of the reasons behind the figures.
We recently attended the 41st J.P. Morgan Healthcare Conference in San Francisco, which took place from January 9th to January 12th 2023. Our overall conclusion from the conference is that the industry remains in good shape. The key themes that emerged during the week from a devices and services perspective were, the rise of value-based care and innovation & digitalisation. However, it also became clear that the macroeconomic environment is still the dominant force behind (sub) sector performance.
Day after day currently feels like a roller coaster ride, going up because of better than hoped for CPI numbers, down because of looming recession fears, and back up because of a less hawkish FED speech. Are we there yet? What do you think?